Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Factors Affecting Mortality in Covid-19 Patients Treated with Intravenous Immunoglobulin

Kadir Ilkkilic,Osman Cure,Hatice Beyazal Polat,Bayram Sen,Esra Aydin,Ugur Avci,Damla Tufekci.




Abstract

Background: Intravenous immunoglobulin (IVIG), used as an option in the treatment of severe Coronavirus disease 2019 (COVID-19), has been shown to have effects on the suppression of the hyperinflammatory state through immunomodulatory actions. The aim of our study was to evaluate the factors associated with mortality in patients treated with IVIG for COVID-19.
Methods: Patients diagnosed with COVID-19 and receiving IVIG therapy in addition to standard care therapy were included in the study.
Results: A total of 46 patients who received IVIG treatment were included in the study. The mortality rate was higher in patients aged over 52 years (p:

Key words: COVID-19; Intravenous immunoglobulin; Charlson Comorbidity Index; Immunoglobulin A; Mortality






Full-text options


Share this Article


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Refer & Earn
JournalList
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.